BioSure

BioSure

BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream.

Founded 2013 11-50 employees Non Equity Assistance Total: $905.00K Health Care, Manufacturing

BioSure is a UK-based startup that is focused on providing rapid in-vitro diagnostic testing solutions. The company's slogan "BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream" encapsulates their mission to make diagnostic testing more accessible. Founded in 2013, BioSure is making strides in the Health Care and Manufacturing industries. The company is committed to expanding the use of rapid testing in healthcare and self-testing. Their goal is to change how disease diagnosis and drug detection are conducted in various settings, including personal, clinical, law enforcement, and commercial environments. Their dedication to making this technology accessible to everyone is evident in their efforts to make it cost-effective, straightforward, speedy, and accurate. In terms of support, BioSure received a Non-Equity Assistance investment from Pitch@Palace on November 7, 2018. This represents a vote of confidence from investors in the potential of BioSure's innovative approach to diagnostic testing. As the company continues to make advancements in the diagnostic testing space, it will be interesting to see how they utilize this support to further their impact in the healthcare and manufacturing industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Non Equity Assistance	Undisclosed	1	Pitch@Palace	07 Nov 2018
Series A	£400.00K	1	VentureFounders	31 Jan 2018
Series A	£505.00K	1	VentureFounders	30 Apr 2017

Funding Stage

Amount

Investors

Lead Investors

Date

Non Equity Assistance

Undisclosed

Pitch@Palace

07 Nov 2018

Series A

£400.00K

VentureFounders

31 Jan 2018

Series A

£505.00K

VentureFounders

30 Apr 2017

FAQ About BioSure

BioSure provides rapid in-vitro diagnostic testing solutions, aiming to bring this technology to the mainstream.

BioSure was founded in 2013.

BioSure operates in Health Care and Manufacturing. Its work centres on In-vitro diagnostic testing, Point-of-care rapid tests, HIV self-test and Diagnostic testing solutions.

BioSure has approximately 11-50 employees.

BioSure has completed 3 funding rounds, raising a total of $905.00K. The latest funding stage is Non Equity Assistance.

Top alternatives and competitors to BioSure include True Diagnostics™, EKF Diagnostics, Verify Diagnostics, Aidian, Surmodics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

BioSure and True Diagnostics™ are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About BioSure

Funding Rounds & Investors (3)

BioSure Alternatives & Competitors

FAQ About BioSure